Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.

Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, Lopez-Doriga A, Santos C, Marijnen C, Westerga J, Bruin S, Kerr D, Kuppen P, van de Velde C, Morreau H, Van Velthuysen L, Glas AM, Van't Veer LJ, Tollenaar R.

J Clin Oncol. 2011 Jan 1;29(1):17-24. doi: 10.1200/JCO.2010.30.1077. Epub 2010 Nov 22.

PMID:
21098318
2.

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.

Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA.

Gut. 2012 Nov;61(11):1560-7. Epub 2012 Jan 2.

PMID:
22213796
3.

Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.

Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507.

4.

Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.

Miyake M, Takemasa I, Matoba R, Tanino M, Niijima S, Ikeda M, Yamamoto H, Sekimoto M, Kuhara S, Okayama T, Monden M, Matsubara K, Mori M.

Int J Oncol. 2011 Oct;39(4):781-9. doi: 10.3892/ijo.2011.1092. Epub 2011 Jun 22.

PMID:
21701771
5.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
6.

Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Wang Z, Xu Y, Wang B, Huang W, Cai S.

Biosci Rep. 2010 Dec;30(6):383-90. doi: 10.1042/BSR20090129.

PMID:
20001967
7.

ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients.

Sveen A, Ågesen TH, Nesbakken A, Meling GI, Rognum TO, Liestøl K, Skotheim RI, Lothe RA.

Clin Cancer Res. 2012 Nov 1;18(21):6001-10. doi: 10.1158/1078-0432.CCR-11-3302. Epub 2012 Sep 18.

8.

E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.

Hebbar M, Adenis A, Révillion F, Duhamel A, Romano O, Truant S, Libersa C, Giraud C, Triboulet JP, Pruvot FR, Peyrat JP.

Eur J Cancer. 2009 Jul;45(10):1871-6. doi: 10.1016/j.ejca.2009.03.011. Epub 2009 Apr 8.

PMID:
19361981
9.
10.

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.

Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.

Clin Cancer Res. 2006 May 1;12(9):2795-803.

11.

Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse.

Al-Mulla F, Behbehani AI, Bitar MS, Varadharaj G, Going JJ.

Mod Pathol. 2006 May;19(5):648-58.

12.

Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.

Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, Nicorici D, Hautaniemi S, Alazzouzi H, Mecklin JP, Järvinen H, Hemminki A, Astola J, Schwartz S Jr, Aaltonen LA.

Gastroenterology. 2005 Sep;129(3):874-84.

PMID:
16143127
13.

Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.

Abulí A, Bessa X, González JR, Ruiz-Ponte C, Cáceres A, Muñoz J, Gonzalo V, Balaguer F, Fernández-Rozadilla C, González D, de Castro L, Clofent J, Bujanda L, Cubiella J, Reñé JM, Morillas JD, Lanas A, Rigau J, García AM, Latorre M, Saló J, Fernández Bañares F, Argüello L, Peña E, Vilella A, Riestra S, Carreño R, Paya A, Alenda C, Xicola RM, Doyle BJ, Jover R, Llor X, Carracedo A, Castells A, Castellví-Bel S, Andreu M; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gastroenterology. 2010 Sep;139(3):788-96, 796.e1-6. doi: 10.1053/j.gastro.2010.05.072. Epub 2010 Jun 2.

PMID:
20638935
14.

Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.

Sarli L, Bottarelli L, Bader G, Iusco D, Pizzi S, Costi R, D'Adda T, Bertolani M, Roncoroni L, Bordi C.

Dis Colon Rectum. 2004 Sep;47(9):1467-82. Epub 2004 Aug 12.

PMID:
15486743
15.

The DCC protein and prognosis in colorectal cancer.

Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele G Jr, Jessup JM, Loda M, Summerhayes IC.

N Engl J Med. 1996 Dec 5;335(23):1727-32.

16.

Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.

Jiang Z, Xu Y, Cai S.

Hum Pathol. 2011 Mar;42(3):361-8. doi: 10.1016/j.humpath.2010.03.009. Epub 2010 Nov 26.

PMID:
21111449
17.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
18.

Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.

Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, Kolch W.

J Clin Oncol. 2006 Dec 20;24(36):5672-9.

PMID:
17179102
19.

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS.

J Clin Oncol. 2005 Apr 20;23(12):2744-53.

PMID:
15837989
20.

Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.

Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ.

J Zhejiang Univ Sci B. 2006 Mar;7(3):235-40.

Supplemental Content

Support Center